NEUROCRINE BIOSCIENCES INC
NBIX
23 insider filings · Latest: May 12, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | Dec 31 9:17 PM | INGRID DELAET | Proposed Sale | 272 | $137.06 | $37.3K | — | View → |
| Dec 17, 2024 | Dec 17 9:29 PM | INGRID DELAET | Proposed Sale | 1,091 | $133.05 | $145.2K | — | View → |
| Nov 29, 2024 | Nov 29 6:41 PM | JUDE ONYIA | Proposed Sale | 2,331 | $126.59 | $295.1K | — | View → |
| Sep 13, 2024 | Sep 13 8:23 PM | DAVID WARREN BOYER | Proposed Sale | 4,756 | $121.28 | $576.8K | — | View → |
← Previous
Page 4 of 4
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 12, 2026 | Feb 17 10:45 PM | Darin LippoldtChief Legal Officer | Option Exercise | 1,792 | — | 5,377(D) | View → |
| Feb 13, 2026 | Feb 17 10:45 PM | Ingrid DelaetChief Regulatory Officer | Option Exercise | 2,760 | — | 1,359(D) | View → |
| Feb 13, 2026 | Feb 17 10:45 PM | Ingrid DelaetChief Regulatory Officer | Grant/Award | 36,713 | $124.12 | 5,479(D) | View → |
| Feb 12, 2026 | Feb 17 10:45 PM | Ingrid DelaetChief Regulatory Officer | Option Exercise | 1,600 | — | 4,801(D) | View → |
| Feb 13, 2026 | Feb 17 10:44 PM | Kevin Charles GormanDirector | Option Exercise | 10,981 | — | 5,377(D) | View → |
| Feb 13, 2026 | Feb 17 10:44 PM | Sanjay Chandru KeswaniChief Medical Officer | Grant/Award | 42,112 | $124.12 | 6,285(D) | View → |
| Jan 31, 2026 | Feb 3 11:22 PM | David W. BoyerChief Corp. Affairs Officer | Option Exercise | 2,096 | — | 0(D) | View → |
| Jan 31, 2026 | Feb 3 11:21 PM | Eric BenevichChief Commercial Officer | Option Exercise | 2,294 | — | 0(D) | View → |
| Jan 31, 2026 | Feb 3 11:06 PM | Matt AbernethyChief Financial Officer | Option Exercise | 2,437 | — | 0(D) | View → |
| Jan 31, 2026 | Feb 3 11:05 PM | Julie CookeChief Human Resources Officer | Option Exercise | 1,741 | — | 0(D) | View → |
| Jan 31, 2026 | Feb 3 11:04 PM | Ingrid DelaetChief Regulatory Officer | Option Exercise | 801 | — | 0(D) | View → |
| Jan 31, 2026 | Feb 3 11:03 PM | Kyle GanoDirector, Chief Executive Officer | Option Exercise | 2,927 | — | 0(D) | View → |
| Jan 31, 2026 | Feb 3 11:02 PM | Kevin Charles GormanDirector | Option Exercise | 5,142 | — | 0(D) | View → |
| Jan 31, 2026 | Feb 3 11:01 PM | Darin LippoldtChief Legal Officer | Option Exercise | 2,373 | — | 0(D) | View → |
| Jan 31, 2026 | Feb 3 11:01 PM | Jude OnyiaChief Scientific Officer | Option Exercise | 238 | — | 0(D) | View → |
| Jan 16, 2026 | Jan 20 11:56 PM | Kyle GanoDirector, Chief Executive Officer | Option Exercise | 36,400 | $35.99 | 0(D) | View → |
← Previous
Page 2 of 2